Our "Book Now" feature should not be used for life threatening conditions such as heart attack, severe injury, poisoning, chest pain, or stroke. If you are experiencing such conditions, STOP and CALL 911 IMMEDIATELY or visit your nearest Emergency Department.
I UnderstandSpecialties
Thoracic Surgery
Education & Training
Doctor of Medicine
Daniel Fortes, MD
Thoracic Surgeon with Wellstar since 2021.
Specialties
Thoracic Surgery
Education & Training
Doctor of Medicine
Based on 80 patient ratings
All reviews have been submitted by patients after seeing the provider.For more information about the review system, check out this Learn more about our review system.
Innovative technology at Wellstar is offering patients a minimally invasive option for lung biopsies, reducing complications and helping expedite lung cancer treatment.
The Ion system is a robotic-assisted platform for performing lung biopsies. If a lung cancer screening or any other CT scan shows a suspicious nodule, providers will need to perform a biopsy to determine if the patient has lung cancer and how to proceed with care.
“Those nodules may not be cancer, but in certain situations we still need to know what it is,” said Wellstar Pulmonologist Dr. Timothy Udoji. “The Ion technology helps us biopsy those nodules to get an answer so that additional workup can be done immediately. If it is cancer, we want to catch it at an early stage.”
The system uses a three-dimensional spatial recognition technology that helps guide a catheter down the airway, deep into the lung, all the way to small nodules where biopsies can be performed. The robotic catheter maintains its shape and stability throughout the biopsy process significantly improving diagnostic yield compared to other modalities.
“The better the image and the more certainty we have of the spatial location of the catheter, the better we can avoid complications by making sure we are not too close to a blood vessel or the edge of the lung,” said Wellstar Thoracic Surgeon Dr. Daniel Fortes.
During the biopsy, providers can also use the Ion system to mark an area in the lung, making it easier to find later during surgery.
“If something is very small and hard to find in surgery, Ion can be used to mark that area with dye, or contrast, that allows us to find it in surgery,” Dr. Fortes said. “With this technology added to the surgical robotic system in the operating room, we can better identify those lesions and remove smaller portions of lung, also called segments.”
The Ion system also has further reach than previous technologies and is able to more easily biopsy nodules in the peripheral areas of the lung. For many cancer patients, this will allow them to initiate care earlier and improve their outcomes, as well as give them peace of mind during the treatment process.
“Mental health impacts physical health. We are able to confidently biopsy and identify these nodules and that means a lot for our patients,” Dr. Udoji said. “Now, with this new technology we are able to get a biopsy done much earlier which has huge outcome implications for malignant nodules.”
At Wellstar, cancer care is tailored for each patient. In the Wellstar STAT Clinic for Lung Cancer, patients meet with multiple specialists at once to discuss their care options and create a personalized treatment plan. Specialists in the STAT Clinics, which are located at Wellstar Cobb, Douglas, Kennestone Regional, North Fulton, Paulding and West Georgia medical centers, as well as Cherokee Health Park, work with patients to determine the optimal course of treatment and will talk with patients and families about biopsy options, including the Ion system. The STAT Clinics give patients the opportunity to have their diagnoses managed right away, and literature shows that the clinics’ diagnostic and treatment model improves outcomes for patients.
The Ion system is in use at Wellstar Kennestone Regional Medical Center, where the team has completed more than 500 procedures. This system is also now available at Wellstar West Georgia Medical Center and Wellstar Douglas Medical Center. Learn more about lung cancer care at wellstar.org/lungcancer and ask your primary care provider or pulmonologist if you have questions or are seeking care for lung health. Learn more about pulmonary care at wellstar.org/pulmonary.
Lung cancer screening can detect cancer earlier—even before symptoms show up. Earlier-stage cancers are more easily treatable. If you are at increased risk of developing lung cancer, you could benefit from regular low-dose CT scans to monitor your lung health.
“Finding lung cancer early leads to better outcomes, and screening with CT scans is recommended as the only proven way to minimize delay in diagnosis,” said Wellstar Thoracic Surgeon Dr. Daniel Fortes.
Our team has built one of the country’s largest and most comprehensive screening programs. Wellstar has been designated as a Screening Center of Excellence and Care Continuum Center of Excellence by the GO2 Foundation, an organization that supports lung cancer patients and educates about screenings and care. We’re also a designated Lung Cancer Screening Center by the American College of Radiology.
The United States Preventive Services Task Force has revised lung screening guidelines. You may qualify for screening if you are 50 to 80 years old and smoked for 20 years. If you are a former smoker, you may qualify if you quit less than 15 years ago.
“Those who are current or past smokers of cigarettes are more likely to develop lung cancer,” Dr. Fortes said. “However, while smoking is the leading risk factor for lung cancer, a large number of lung cancer patients have never smoked—1 in 5 women and 1 in 10 men diagnosed with lung cancer were never smokers.”
You may also be at increased risk of developing lung cancer if you have been exposed to radon, asbestos or other agents such as uranium or arsenic, according to the American Cancer Society. Previous radiation therapy in the lung area, such as chest radiation for breast cancer treatment, can also increase risk. Additionally, be sure to discuss your family history with your provider—siblings and children of people who have had lung cancer may have a higher risk of developing it.
Screening for lung cancer is not a one-time test, but a process that involves a periodic evaluation of your lungs over time to look for newly emerging cancer. CT scans can detect nodules that are compared over time for changes in size.
“For those who are at high risk for lung cancer, it is best to have nodules and lung health evaluated by a team of physicians specializing in lung cancer care so the appropriate decision can be made of continued observation versus the need for early intervention,” Dr. Fortes said.
Depending on the findings, some patients may have more or fewer exams. If findings are suspicious for lung cancer, your care team will contact you to discuss your screening results.
An order from your physician is required to get a screening. Contact your primary care team or a pulmonologist to talk about screening and when it may be right for you. Once an order has been obtained from your physician, call (470) 793-4AIR (4247) to schedule your appointment.
Your care team will support you at every step of the screening process. If you have any questions about your results or your screening plan, contact your provider over the phone or using the secure messaging feature in MyChart. You can also call our cancer care team at (877) 366-6032 to learn about our care options.
All lung screenings are initially interpreted by a radiologist. A team of physicians who specialize in the diagnosis and treatment of lung cancer will review findings that are suspicious for cancer. Once the physicians complete their review of your images, your results are posted within three to five days to your MyChart account. Results will be communicated with you and your physician via MyChart or mail within one week.
If a lung cancer is suspected, our team will call you to answer your questions and arrange next steps. You will then meet with a physician specializing in lung cancer treatment.
Patients whose screening shows a lung nodule may feel concerned. However, you should not be overly concerned if your report indicates you have small lung nodules. Most people who meet eligibility for screening will have some. Nodules are very common—at least 50% of people have them by the time they are 50 years old.
Learn more at wellstar.org/lungcancer.
Daniel Fortes, MD
Thoracic Surgeon with Wellstar since 2021
|
|
Specialties
Thoracic Surgery
Education
Doctor of Medicine
Medical School
Universidade Federal Do Rio Grande Do Sul
Residency
University of Texas Health Sciences Center
Fellowship
Mayo Clinic College of Medicine
Certifications
American Board of Thoracic Surgery
Spoken Languages
English, Portuguese and Spanish - Medical
Hospital Affiliations
Wellstar Cobb Hospital Wellstar Kennestone Hospital Wellstar North Fulton Hospital Wellstar Douglas Hospital Wellstar Paulding Medical Center Wellstar Windy Hill Hospital Wellstar Spalding Regional Hospital Wellstar West Georgia Medical Center Wellstar MCG Health Medical Center
Office Locations
|
|
www.wellstar.org/physicians/daniel-fortes-md
|
